P Gisondi Selected Research

P Gisondi Research Topics

Disease

47	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 12/2006
5	Infections 04/2021 - 06/2014
5	COVID-19 04/2021 - 01/2020
4	Skin Diseases (Skin Disease) 01/2022 - 12/2017
4	Psoriatic Arthritis 01/2020 - 03/2012
3	Necrosis 01/2021 - 03/2008
3	Obesity 08/2020 - 04/2013
3	Body Weight (Weight, Body) 01/2020 - 03/2008
2	Hypertension (High Blood Pressure) 01/2013 - 07/2007
1	Skin Ulcer 12/2021
1	Virus Diseases (Viral Diseases) 11/2021
1	Pain (Aches) 01/2021
1	Hidradenitis Suppurativa 01/2021
1	Atherosclerotic Plaque (Atheroma) 08/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2020
1	Non-alcoholic Fatty Liver Disease 08/2020
1	Atopic Dermatitis (Atopic Eczema) 06/2020
1	Rheumatic Diseases (Rheumatism) 01/2020
1	Joint Diseases (Joint Disease) 04/2018
1	Hepatitis B 11/2017
1	Hepatitis 11/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2017
1	Solar Urticaria 09/2016
1	Anaphylaxis (Anaphylactic Shock) 09/2016
1	Exercise-Induced Allergies 09/2016
1	Tuberculosis (Tuberculoses) 10/2014
1	Latent Tuberculosis 10/2014
1	Inflammation (Inflammations) 04/2013
1	Diabetes Mellitus 01/2013
1	Arthritis (Polyarthritis) 04/2012
1	Rare Diseases (Rare Disease) 04/2012
1	Arthralgia (Joint Pain) 04/2012
1	Dermatitis 04/2012
1	Vasculitis (Vasculitides) 04/2012

Drug/Important Bio-Agent (IBA)

9	Infliximab (Remicade)FDA Link 01/2020 - 03/2008
6	Etanercept (Enbrel)FDA Link 12/2019 - 03/2008
5	Biological ProductsIBA 01/2021 - 12/2013
5	Adalimumab (Humira)FDA Link 01/2021 - 06/2013
4	Pharmaceutical PreparationsIBA 11/2017 - 01/2011
3	secukinumabIBA 01/2020 - 12/2017
3	Acitretin FDA Link 01/2019 - 02/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2011 - 03/2008
2	Advanced Glycation End ProductsIBA 01/2022 - 01/2022
2	apremilastIBA 01/2021 - 12/2017
2	InterleukinsIBA 08/2020 - 01/2020
2	Biosimilar PharmaceuticalsIBA 01/2020 - 12/2017
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2006
2	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 03/2008
2	SteroidsIBA 04/2018 - 04/2009
2	AdipokinesIBA 09/2017 - 04/2013
2	calcipotriene (calcipotriol)FDA LinkGeneric 07/2017 - 06/2015
2	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 07/2017 - 06/2015
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2016 - 01/2013
2	Ustekinumab (CNTO 1275)FDA Link 10/2014 - 05/2013
2	Triglycerides (Triacylglycerol)IBA 04/2013 - 01/2013
2	C-Reactive ProteinIBA 04/2013 - 10/2010
2	Folic Acid (Vitamin M)FDA LinkGeneric 10/2010 - 12/2006
2	HomocysteineIBA 10/2010 - 12/2006
1	risankizumabIBA 01/2022
1	tildrakizumabIBA 11/2021
1	dimemorfan (AT 17)IBA 03/2021
1	brodalumabIBA 03/2021
1	Prostaglandins AIBA 03/2021
1	Immunomodulating AgentsIBA 01/2021
1	Interleukin-23 (Interleukin 23)IBA 08/2020
1	InterferonsIBA 01/2020
1	AntibodiesIBA 01/2020
1	S100 Calcium Binding Protein A7IBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	ixekizumabIBA 01/2019
1	etanercept biosimilar SB4IBA 01/2019
1	CT-P13IBA 12/2017
1	Betamethasone (Celestone)FDA Link 07/2017
1	ElementsIBA 07/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 10/2016
1	Cholinergic Agents (Cholinergics)IBA 09/2016
1	Isoniazid (Ftivazide)FDA LinkGeneric 10/2014
1	GoldIBA 10/2014
1	Monoclonal AntibodiesIBA 06/2013
1	ResistinIBA 04/2013
1	LipidsIBA 04/2013
1	EnzymesIBA 04/2013
1	CholesterolIBA 04/2013
1	Biomarkers (Surrogate Marker)IBA 04/2013
1	Nicotinamide PhosphoribosyltransferaseIBA 04/2013
1	LDL CholesterolIBA 01/2013
1	CreatinineIBA 01/2013
1	TransferasesIBA 01/2013
1	Aspartic Acid (Aspartate)FDA Link 01/2013
1	Alanine (L-Alanine)FDA Link 01/2013
1	MucinsIBA 04/2012
1	Immunoglobulin D (IgD)IBA 04/2012
1	hydroxide ionIBA 03/2012

Therapy/Procedure

15	Therapeutics 04/2021 - 03/2008
6	Biological Therapy 06/2021 - 12/2011
1	Transplantation 12/2021
1	Immunotherapy 04/2021
1	Subcutaneous Injections 01/2020
1	Injections 04/2018
1	Skin Care 12/2017